13F filer · CIK 1422848 ↗
Capital Research Global Investors
You are looking at Q4 2017. See the latest, Q2 2026 →
Reported value
$340.76B
+2.9% on the quarter before
Positions
432
26 new · 26 sold out
Top 10
25.4%
of the value
Est. gain
+$20.14B
on stocks held all quarter
Est. return
+6.6%
on those stocks since Q3 2017
Positions as of Dec 31, 2017, from Capital Research Global Investors's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 43% of the reported value, each sized by its share, colored by what the fund did with it since Q3 2017. Striped tiles are options.
Largest buys
Since Q3 2017, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Worldpay Inc Cl A~$1.17BNew · 0.0% → 0.3%+15,844,393 shares
- Nike Inc Cl B~$1.05BAdded · 0.4% → 0.8%+16,851,699 shares
- Abbott Laboratories~$986.1MAdded · 1.1% → 1.4%+17,279,533 shares
- Gilead Sciences Inc~$749.0MAdded · 0.5% → 0.7%+10,454,610 shares
- General Electric Co~$654.9MAdded · 0.9% → 0.9%+37,530,900 shares
- Teva Pharmaceutical Industries Ltd ADR~$543.0MAdded · 0.4% → 0.5%+28,656,135 shares
- Costco Wholesale Corp~$529.0MAdded · 0.5% → 0.7%+2,842,473 shares
- American Electric Power~$443.7MAdded · 0.2% → 0.4%+6,031,560 shares
- Express Scripts Holding Co~$421.0MAdded · 0.3% → 0.4%+5,639,990 shares
- Abbvie Inc~$386.4MAdded · 5.1% → 5.5%+3,995,594 shares
Largest sells
Since Q3 2017, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Oracle~$3.26BCut · 1.3% → 0.3%−69,005,040 shares
- Apple~$1.66BCut · 1.3% → 0.9%−9,817,890 shares
- Bbandt Corporation~$1.12BCut · 0.4% → 0.0%−22,600,488 shares
- Vantiv Inc Cl A~$1.04BSold out · 0.3% → 0.0%−14,693,945 shares
- Priceline Group Inc (The)~$1.00BCut · 0.9% → 0.6%−577,432 shares
- Intel~$976.2MCut · 1.7% → 1.8%−21,147,303 shares
- Alibaba~$919.9MCut · 1.7% → 1.3%−5,334,991 shares
- Union Pacific Corp~$798.8MCut · 0.8% → 0.6%−5,956,687 shares
- Amazon~$794.0MCut · 3.1% → 3.4%−678,982 shares
- Kroger Co~$622.0MCut · 0.3% → 0.3%−22,659,645 shares
Holdings
As of Dec 31, 2017. Changes are in shares against Sep 30, 2017, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Abbvie IncCOMMON STOCK · shares +2.1% · price +8.8% | 5.5% | $18.67B | +$1.48B | ||||||||
| AmazonCOMMON STOCK · shares −6.4% · price +21.6% | 3.4% | $11.62B | +$2.07B | ||||||||
| Amgen IncCOMMON STOCK · shares −3.0% · price −6.7% | 2.6% | $8.86B | −$639.1M | ||||||||
| NetflixCOMMON STOCK · shares −4.2% · price +5.9% | 2.5% | $8.63B | +$477.0M | ||||||||
| Verizon Communications IncCOMMON STOCK · shares −0.3% · price +7.0% | 2.5% | $8.38B | +$544.9M | ||||||||
| MicrosoftCOMMON STOCK · shares +5.6% · price +14.8% | 2.1% | $7.22B | +$883.1M | ||||||||
| Broadcom LtdCOMMON STOCK · shares −8.7% · price +5.9% | 1.8% | $6.25B | +$349.4M | ||||||||
| IntelCOMMON STOCK · shares −14% · price +21.2% | 1.8% | $6.02B | +$1.05B | ||||||||
| Philip Morris InternationalCOMMON STOCK · shares +1.4% · price −4.8% | 1.6% | $5.54B | −$277.2M | ||||||||
| AlphabetCOMMON STOCK · shares −0.9% · price +9.1% | 1.5% | $5.26B | +$438.9M | ||||||||
| Csx CorpCOMMON STOCK · shares −6.9% · price +1.4% | 1.5% | $5.00B | +$68.2M | ||||||||
| Abbott LaboratoriesCOMMON STOCK · shares +25% · price +7.0% | 1.4% | $4.86B | +$251.8M | ||||||||
| Eog Resources IncCOMMON STOCK · shares −3.4% · price +11.5% | 1.4% | $4.73B | +$489.6M | ||||||||
| Stryker CorpCOMMON STOCK · shares −2.0% · price +9.0% | 1.4% | $4.69B | +$387.9M | ||||||||
| AlibabaCOMMON STOCK · shares −17% · price −0.2% | 1.3% | $4.60B | −$7.5M | ||||||||
| AlphabetCOMMON STOCK · shares −0.8% · price +8.2% | 1.3% | $4.51B | +$341.1M | ||||||||
| Unitedhealth Group IncCOMMON STOCK · shares −1.5% · price +12.6% | 1.3% | $4.45B | +$496.8M | ||||||||
| Texas InstrumentsCOMMON STOCK · shares −9.4% · price +16.5% | 1.3% | $4.29B | +$608.2M | ||||||||
| Accenture Plc Cl ACOMMON STOCK · shares −4.5% · price +13.3% | 1.2% | $4.19B | +$493.2M | ||||||||
| Home Depot IncCOMMON STOCK · shares +1.0% · price +15.9% | 1.1% | $3.83B | +$520.0M | ||||||||
| Twenty-First Century Fox Inc Cl A (Limited Voting)COMMON STOCK · shares +9.7% · price +30.9% | 1.1% | $3.74B | +$805.1M | ||||||||
| Thermo Fisher Scientific IncCOMMON STOCK · shares +6.0% · price +0.4% | 1.1% | $3.71B | +$12.5M | ||||||||
| General Dynamics CorpCOMMON STOCK · shares +6.8% · price −1.0% | 1.1% | $3.70B | −$36.3M | ||||||||
| Canadian Natural Resources LtdCOMMON STOCK · shares +2.1% · price +6.7% | 1.1% | $3.67B | +$225.8M | ||||||||
| American International Group IncCOMMON STOCK · shares −0.00% · price −2.9% | 1.0% | $3.43B | −$104.2M | ||||||||
| Total · 432 positions | 100% | $340.76B | +$20.14B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q3 2017 to Q4 2017: 399 stocks held throughout, up $20.14B (+6.6%).
- Amazon+$2.07B+22%
- Abbvie Inc+$1.48B+9%
- Intel+$1.05B+21%
- Microsoft+$883.1M+15%
- Twenty-First Century Fox Inc Cl A (Limited Voting)+$805.1M+31%
- Gilead Sciences Inc−$205.1M−12%
- Nielsen Holdings Plc−$207.8M−12%
- Philip Morris International−$277.2M−5%
- Amgen Inc−$639.1M−7%
- General Electric Co−$870.3M−28%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 1 split read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 12, 2026 | $716.87B+11% | SEC ↗ |
| Q1 2026 | May 13, 2026 | $644.56B+19% | SEC ↗ |
| Q4 2025 | Feb 11, 2026 | $541.73B+2% | SEC ↗ |
| Q3 2025 | Nov 13, 2025 | $532.97B+7% | SEC ↗ |
| Q2 2025 | Aug 13, 2025 | $499.46B+9% | SEC ↗ |
| Q1 2025 | May 12, 2025 | $459.90B−5% | SEC ↗ |
| Q4 2024 | Feb 13, 2025 | $486.38B+1% | SEC ↗ |
| Q3 2024 | Nov 13, 2024 | $481.14B+6% | SEC ↗ |
| Q2 2024 | Aug 13, 2024 | $455.74B+3% | SEC ↗ |
| Q1 2024 | May 14, 2024 | $441.98B+9% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 | $406.47B+12% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $363.16B−3% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $373.18B+7% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $350.40B+6% | SEC ↗ |
| Q4 2022 | Feb 14, 2023 | $330.88B+9% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $304.37B−5% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $321.05B−21% | SEC ↗ |
| Q1 2022 | May 19, 2022 (amended) | $405.10B−11% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $452.67B+6% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $428.65B−0% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $429.52B+5% | SEC ↗ |
| Q1 2021 | May 14, 2021 | $408.71B+6% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $385.30B+16% | SEC ↗ |
| Q3 2020 | Nov 13, 2020 | $333.11B+5% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $316.13B+24% | SEC ↗ |
| Q1 2020 | May 15, 2020 | $254.90B−24% | SEC ↗ |
| Q4 2019 | Feb 18, 2020 | $333.48B+9% | SEC ↗ |
| Q3 2019 | Nov 14, 2019 | $304.85B−3% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $314.99B−0% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $315.45B+10% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $287.02B−17% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $344.02B−6% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $366.12B+4% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $351.43B+3% | SEC ↗ |
| Q4 2017 | Feb 14, 2018 | $340.76B+3% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $331.24B+4% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $319.49B+1% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $317.04B+3% | SEC ↗ |
| Q4 2016 | Feb 15, 2017 | $308.47B+2% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $302.53B+3% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $292.47B+1% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $290.06B | SEC ↗ |